Polar Asset Management Partners’s Harvard Bioscience HBIO Stock Holding History

Polar Asset Management Partners’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-104,836	Closed	-$2.85M	–	286
2016 Q3	$2.85M	Sell	104,836 -59,234	-36%	-$1.64M	0.09%	171
2016 Q2	$4.69M	Sell	164,070 -6,959	-4%	-$221K	0.19%	133
2016 Q1	$5.17M	Sell	171,029 -670	-0.4%	-$19K	0.22%	112
2015 Q4	$5.96M	Buy	171,699 +20,243	+13%	+$692K	0.31%	90
2015 Q3	$5.72M	Buy	151,456 +73,453	+94%	+$3.42M	0.35%	94
2015 Q2	$4.45M	Buy	78,003 +4,358	+6%	+$248K	0.19%	120
2015 Q1	$4.29M	Buy	+73,645	New	+$3.96M	0.23%	123

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPC

Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Polar Asset Management Partners's HBIO Position: Q4 2016 in Review

Polar Asset Management Partners sold out of Harvard Bioscience (HBIO) in Q4 2016, closing a stake of 104,836 shares — an estimated $2.85M sold.

Polar Asset Management Partners first reported a position in HBIO in Q1 2015 and held it in 7 quarters. The position peaked at $5.96M in Q4 2015. 68 funds tracked by Wall St. Rank hold HBIO as of Q4 2016.

Polar Asset Management Partners reported no remaining Harvard Bioscience position as of Q4 2016 after selling out during the quarter.
Polar Asset Management Partners sold 104,836 Harvard Bioscience shares in Q4 2016, an estimated $2.85M.
Polar Asset Management Partners first reported a position in Harvard Bioscience in Q1 2015 and held it in 7 quarters.
Polar Asset Management Partners's Harvard Bioscience position peaked at $5.96M in Q4 2015.
68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2016.

Based on Polar Asset Management Partners's 13F filing for Q4 2016, filed 14 Feb 2017.